Shridar Ganesan
Rutgers University-New Brunswick, NJ·Medicine & Clinical Research
Moving discoveries from the laboratory into treatments for cancer patients requires a bridge between basic research and the clinic. This grant supports the Clinical Investigations and Precision Therapeutics Program, a group of about 80 researchers across many departments in a cancer center.
- Fields
Medicine & Clinical Research
Pharmacology
- Topics
precision oncology
cancer
clinical trials
- Grants
- 1 known grant, through Feb 2029
What they work on
- Target metabolic, cell death, and cell survival pathways in cancer and translate promising findings into early-phase clinical trials.
- Target abnormalities in DNA repair and cell cycle checkpoints, the safeguards that halt cell division after DNA damage, as cancer treatment strategies.
- Target the tumor immune microenvironment, the immune cells and signals around a tumor, in collaboration with cancer immunology investigators.
- Investigate markers of response and resistance to cancer therapy, supported by a Molecular Tumor Board and a Precision Oncology Initiative.
More about the research
The program turns laboratory findings into early-phase clinical trials, develops new strategies for diagnosis, prevention, and treatment, and feeds clinical observations back to the lab.
Why it matters
By moving laboratory findings into early-phase clinical trials, the program could give cancer patients access to new treatments matched to their tumors. Research on response and resistance markers may help doctors choose therapies more likely to work. Work on DNA repair, cell survival, and the tumor immune environment could reveal new treatment targets.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Samir Parekh
Icahn School of Medicine at Mount Sinai, NY·Medicine & Clinical Research
Translate findings from cancer immunology and cancer mechanism laboratories into investigator-initiated clinical trials through Clinical Trial Incubators, Drug Discovery Clinics and Tumor Working Groups.
Paul Crispen
University of Florida, FL·Medicine & Clinical Research
Support the development, activation, and regulatory compliance of investigator-initiated, NCI-sponsored, and industry cancer trials through a centralized Clinical Research Office at UF Health Cancer Center.
Yusuf Menda
University of Iowa, IA·Medicine & Clinical Research
Fund two pilot projects each year in neuroendocrine tumor research, spanning population, laboratory, and clinical studies, with continued support for those that make progress.
The school
Rutgers University-New Brunswick: 57 labs on PI Pages, $837M a year on research, 713 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.